Marco Randazzo is a cheminformatic data scientist with a research background in chemistry, machine-learning (ML), and cheminformatics applied in drug discovery. He has developed ML and cheminformatics tools for automatic compound annotation in metabolomics approach at the University of Geneva. Giuseppe Marco also worked in a joint venture between the University of Geneva and a private industrial partner Firmenich, delivering new active nature-identical compounds. He also worked for the Dalle Molle Institute for Artificial Intelligence (IDSIA) and later for Hoffmann-La Roche, implementing new AI methods for drug discovery. Marco completed his Ph.D. in chemical science at the laboratory of chemometrics and cheminformatic University of Perugia (Italy). Currently he works for Endogena Therapeutics as Head of AI and Cheminformatics.
I'm sorry, but now there's a STUPID law made by people who DONT understand how the internet works that force us to have this banner that says, "This website uses cookies to improve your experience. I'll assume you're ok with this, but you can opt out if you wish." Read more in Cookies Policy.